Cargando…
FRONTIERS IN CLINICAL DRUG RESEARCH - CNS AND NEUROLOGICAL DISORDERS, VOLUME 4.
Annotation
| Clasificación: | Libro Electrónico |
|---|---|
| Autor principal: | |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
[Place of publication not identified] :
BENTHAM Science PUBLISHER,
2016.
|
| Temas: | |
| Acceso en línea: | Texto completo |
MARC
| LEADER | 00000cam a2200000M 4500 | ||
|---|---|---|---|
| 001 | EBSCO_ocn967194255 | ||
| 003 | OCoLC | ||
| 005 | 20231017213018.0 | ||
| 006 | m o d | ||
| 007 | cr ||||||||||| | ||
| 008 | 161228s2016 xx o 000 0 eng d | ||
| 040 | |a YDX |b eng |c YDX |d OCLCQ |d N$T |d G3B |d IGB |d STF |d OCLCF |d VT2 |d SFB |d OCLCO |d OCLCQ |d OCLCO | ||
| 020 | |a 1681082950 |q (electronic bk.) | ||
| 020 | |a 9781681082950 |q (electronic bk.) | ||
| 035 | |a (OCoLC)967194255 | ||
| 050 | 4 | |a RC346 | |
| 072 | 7 | |a HEA |x 039000 |2 bisacsh | |
| 072 | 7 | |a MED |x 014000 |2 bisacsh | |
| 072 | 7 | |a MED |x 022000 |2 bisacsh | |
| 072 | 7 | |a MED |x 112000 |2 bisacsh | |
| 072 | 7 | |a MED |x 045000 |2 bisacsh | |
| 082 | 0 | 4 | |a 616.8 |2 23 |
| 049 | |a UAMI | ||
| 100 | 1 | |a ATTA-UR-RAHMAN. | |
| 245 | 1 | 0 | |a FRONTIERS IN CLINICAL DRUG RESEARCH - CNS AND NEUROLOGICAL DISORDERS, VOLUME 4. |
| 260 | |a [Place of publication not identified] : |b BENTHAM Science PUBLISHER, |c 2016. | ||
| 300 | |a 1 online resource | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 588 | |a Online resource; title from PDF title page (EBSCO, viewed January 8, 2019). | ||
| 520 | 8 | |a Annotation |b Frontiers in Clinical Drug Research - CNS and Neurological Disorders is an eBook series that brings updated reviews to readers interested in advances in the development of pharmaceutical agents for the treatment of central nervous system (CNS) and other nerve disorders. The scope of the eBook series covers a range of topics including the medicinal chemistry, pharmacology, molecular biology and biochemistry of contemporary molecular targets involved in neurological and CNS disorders. Reviews presented in the series are mainly focused on clinical and therapeutic aspects of novel drugs intended for these targets. Frontiers in Clinical Drug Research - CNS and Neurological Disorders is a valuable resource for pharmaceutical scientists and postgraduate students seeking updated and critical information for developing clinical trials and devising research plans in the field of neurology.The fourth volume of this series features reviews that cover a variety of topics including:-Multiple sclerosis drug therapy-Treatment of diabetic neuropathy-Migraine treatments-Ischemic stroke treatments-Alzheimer's disease biomarkers. | |
| 505 | 8 | |a Polyol Pathway -- Protein Kinase C -- Hexosamine Pathway -- Low C-peptide Concentration -- Proinflammatory Cytokines -- Neurotrophic Factors -- Angiotensin-converting Enzyme -- Kinin B1 Receptor -- TREATMENT OF DIABETIC NEUROPATHY -- Treatment of Diabetes Mellitus -- Adequate Compensation -- Supportive and Additional Treatment -- Alpha-lipoic Acid -- Symptomatic Treatment -- Treatment in Experimental and Clinical Studies -- Anti-inflammatory Drugs -- Neurotrophic Factors -- Angiotensin Converting enzyme (ACE) Inhibitors -- Novel Drugs with Antioxidant Functions -- Non-pharmacological Therapy -- inhibitors of Epigenetic Modifications -- CONCLUSION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENT -- REFERENCES -- The Now and Tomorrow of Migraine Treatments -- INTRODUCTION -- PATHOPHYSIOLOGICAL OVERVIEW -- ACUTE ATTACK TREATMENT -- Currently Available Drugs -- Nonsteroidal Anti-inflammatory Drugs (NSAIDs) -- Ergot Alkaloids and Triptans -- Combination Regimens -- Narcotic Analgesics -- Hyperbaric Oxygen Therapy -- Medication Overuse Headache -- Novel Targets for Attack Treatment -- CGRP -- NOS Inhibition -- TRP Channels -- Glutamate Receptors -- PACAP-38 -- Cannabinoids -- The Parenchymal Inflammatory Cascade -- PROPHYLACTIC TREATMENT -- Currently Available Drugs -- Antiepileptics -- Antidepressants -- Beta Blockers -- Calcium Channel Blockers -- Glutamate Receptor Antagonists -- Triptans -- Novel Targets for Prophylactic Treatment -- CGRP -- NOS Inhibition -- Gap Junction Blockers -- Renin-Angiotensin System -- Acid Sensing Ion Channels -- Botulinum Neurotoxin -- CONCLUDING REMARKS -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- The Now and Tomorrow of Ischemic Stroke Treatment -- ADVANCES IN TREATMENT OF ACUTE ISCHEMIC STROKE -- Recanalization/Reperfusion -- Neuro-Glial Protection -- Prevention of Secondary Complications. | |
| 505 | 8 | |a ADVANCES IN SECONDARY PROPHYLAXIS OF ISCHEMIC STROKE -- CONCLUDING REMARKS -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- SUBJECT INDEX. | |
| 590 | |a eBooks on EBSCOhost |b EBSCO eBook Subscription Academic Collection - Worldwide | ||
| 650 | 0 | |a Central nervous system. | |
| 650 | 0 | |a Nervous system |x Diseases. | |
| 650 | 2 | |a Central Nervous System | |
| 650 | 2 | |a Nervous System Diseases | |
| 650 | 6 | |a Système nerveux central. | |
| 650 | 6 | |a Système nerveux |x Maladies. | |
| 650 | 7 | |a HEALTH & FITNESS / Diseases / General. |2 bisacsh | |
| 650 | 7 | |a MEDICAL / Clinical Medicine. |2 bisacsh | |
| 650 | 7 | |a MEDICAL / Diseases. |2 bisacsh | |
| 650 | 7 | |a MEDICAL / Evidence-Based Medicine. |2 bisacsh | |
| 650 | 7 | |a MEDICAL / Internal Medicine. |2 bisacsh | |
| 650 | 7 | |a Central nervous system |2 fast | |
| 650 | 7 | |a Nervous system |x Diseases |2 fast | |
| 856 | 4 | 0 | |u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=1280046 |z Texto completo |
| 938 | |a YBP Library Services |b YANK |n 13312956 | ||
| 938 | |a EBSCOhost |b EBSC |n 1280046 | ||
| 994 | |a 92 |b IZTAP | ||